drugset / Trial / NCT00183430

Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder

NCT00183430

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the effectiveness of prazosin in treating post-traumatic stress disorder caused by noncombat trauma in individuals taking selective serotonin reuptake inhibitors.

Timeline

Start
2003-10
Primary completion
2009-05
Completion
2010-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Prazosin Unknown 1 mg Oral
Subject Prazosin Unknown 25 mg Oral